glenmarkpharma.com Listed by incransom Ransomware Group: Ransomware Claim — What’s Alleged & What To Do
glenmarkpharma.com was listed by the incransom ransomware group on March 25, 2026, with internal files reported to have been exfiltrated. An undisclosed number of people may be affected; anyone who has interacted with the organisation should review their accounts and monitor for suspicious activity.
Breaking down the breach
The incident is known only through the group's public listing of the domain. No official statement from Glenmark Pharmaceuticals has been referenced in available records, and details such as the date of the intrusion, the volume of data taken, or the method of access remain undisclosed. The entry describes exfiltration of internal files but provides no further inventory or confirmation of encryption or ransom demands.
Inside incransom
Incransom is a ransomware operation that maintains a leak site to publicize claimed victims. Such groups typically gain initial access through phishing, exposed remote services, or supply-chain weaknesses, then move laterally to locate and copy data before deploying encryption. The listing of glenmarkpharma.com constitutes the group's claim; independent verification of the data's contents or the circumstances of the intrusion has not been published.
About glenmarkpharma.com
Glenmark Pharmaceuticals was founded in 1977 and is headquartered in Mumbai, India. It develops, manufactures, and markets pharmaceutical products across more than 25 countries in North America, South America, Europe, Asia, Africa, and the Middle East. The company maintains research and development programs and holds a portfolio spanning multiple therapeutic areas that serves both commercial and consumer markets.
What data was at risk
The listing refers only to “internal files.” No specific categories such as employee records, clinical trial data, manufacturing documents, or customer information have been named. Pharmaceutical companies routinely hold research data, regulatory submissions, supply-chain records, and personal information of staff and trial participants; however, the precise contents of the exfiltrated material have not been confirmed.
What's at stake
Exposure of internal pharmaceutical files can affect competitive research positions and regulatory compliance obligations. For individuals whose information may be included, possible consequences include targeted fraud or misuse of personal identifiers. The organization faces potential regulatory scrutiny and operational disruption, though the scale of either remains unknown at this stage.
If your data was in this claimed breach
Monitor accounts for unusual activity and change passwords for any services linked to Glenmark Pharmaceuticals. Enable multi-factor authentication where available. Individuals can run a free exposure scan of their email address against known breach data to determine whether their information appears in public listings from this or other incidents.
AICompiled with AI assistance from public sources and published under our editorial standards.
How this breach connects
More recent breaches
polymedicure.com Listed by incransom Ransomware GroupAesthetic Surgical Images Listed by incransom Ransomware GroupColorado Rehabilitation & Occupational Medicine Claimed by IncRansomhamilton-eye.com Listed by incransom Ransomware GroupLatest breaches
Read GalaxyWarden’s full analysis of the glenmarkpharma.com Listed by incransom Ransomware Group →
Publicly posted by incransom — unverified claim, pending independent verification
Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.
Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.